A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.
CONCLUSIONS: Our results suggest the presence of EGFR wild-type, KRAS gene mutations or squamous cell carcinoma were associated with high PD-L1expression, which provides potential benefited population for the administration of PD-1/PD-L1 blockade in human lung cancer.
PMID: 28932563 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Sarcomas | Skin Cancer | Squamous Cell Carcinoma | Study